Dana left her last primary care visit with eight minutes of attention, a basic panel and the word “normal.” She still wakes at 3 AM. She still loses words in meetings she used to run without notes. Dana is a composite, not a real patient. She stands in for one particular reader: someone who already pays for longevity testing and a hormone clinic, wants nothing to do with a pill mill and now has the brochure of a $20,000-a-year concierge practice open on her desk.
Her question is the one behind a search for cardiometabolic optimization vs concierge medicine. She wants to know what the first phrase means before she spends $20,000 on the second. The short answer is that cardiometabolic optimization treats weight, hormones, thyroid, insulin, blood sugar, lipids and inflammation as one system, read by one clinician from the same blood and followed every quarter. GoodLife Health delivers it as a membership that sits between the $20,000-a-year concierge practice and the $99-a-month compounded app, with quarterly labs and a clinician who stays. This piece follows what we would check for someone in Dana's position in her first 90 days and why.
- Cardiometabolic optimization reads weight, hormones, thyroid, insulin, lipids and inflammation as one system.
- GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app.
- Every quarter brings a panel with Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP and Fasting Insulin, with every result in your hands.
- Medication goes to your chosen pharmacy at its own price, with nothing taken by GoodLife Health.
- The membership is $299 a month. At sign-up, $598 is held for the first two months, released if you are not accepted and non-refundable once you are.
- The first 90 days bring two panels and a clinician's reading, with no promise of what they will show.
Eight minutes, three subscriptions and nobody reading the whole
Dana runs operations for a mid-sized company. She reads the appendix of every report before she reads the summary. She brings the same habit to her health, which is why she has spent real money on it. She pays for a consumer lab membership that sends her a dashboard of results. She pays a hormone clinic by the month. She wears a ring that scores her sleep every morning. The score has not been good for a long time.
Over the same stretch, the scale has climbed somewhere between 15 and 25 pounds, depending on the week. Her clothes fit differently. Her energy drops in the middle of the afternoon. The fog bothers her most, because her work depends on her being the clearest person in the room.
Last spring, she booked a visit with the practice her insurance plan assigns. The visit lasted eight minutes. A basic panel came back with nothing flagged. The clinician summed it up in two sentences: “It's just perimenopause. Eat fewer carbs.” Nobody drew fasting insulin. Nobody mentioned ApoB. Nobody asked what the hormone clinic was prescribing.
The three things Dana pays for do not talk to each other. The hormone clinic adjusts a dose without seeing her lipids. The lab membership shows her colored ranges with no clinician to read them with her. The primary care practice sees her once a year for eight minutes. Each does its own part competently. None of them owns the whole picture.
So she started looking at concierge medicine. The practice in her brochure charges $20,000 a year and promises time, access and a doctor who knows her name. She is willing to pay for that. She is not willing to pay $20,000 for the same tests read the same way in a nicer waiting room.
She has also seen the other end of the market. Apps advertise a GLP-1 prescription for $99 a month after a short questionnaire. She does not want to become a pill mill's next order. She wants someone to find out why she feels this way before anyone writes a prescription.
When she first read the phrase cardiometabolic optimization on our site, it sounded like one more piece of wellness vocabulary. That suspicion is reasonable. The rest of this piece is our answer to it.
What the phrase means in a body like Dana's
Cardiometabolic optimization starts from an observation about biology. The systems that Dana's three subscriptions treat separately are connected. Our definitive guide to cardiometabolic optimization describes the chain in four steps. Insulin resistance drives weight gain. Visceral fat disrupts hormones. Disrupted hormones stall metabolism. Stalled metabolism feeds vascular inflammation. A provider who sees one link at a time can keep adjusting that link while the chain keeps running.
So the definition is about structure. Cardiometabolic optimization means one clinician reads insulin, blood sugar, thyroid, lipids and inflammation from the same draw, decides what they mean together and checks again every 90 days to see whether the plan is working. Weight and hormones sit inside that picture because the chain runs through both of them. A dose adjusted without the rest of the panel is a guess. A dose adjusted against it is a decision.
The word “normal” deserves its own paragraph, because that is where Dana's last visit ended. A basic panel flags a value when it falls outside a reference range. That range describes a population. The definitive guide cites national survey data (NHANES 2009–2016) showing that only 12% of U.S. adults are metabolically healthy. A result inside a range drawn from that population tells Dana how she compares with it. It does not tell her where her own markers are heading, which is the question she actually has.
Normal is a population range drawn from people who are not you.
The field is moving toward testing first. GoodLife Health draws Apolipoprotein B (ApoB), Lipoprotein (A) and Hs-CRP in every panel beside the Lipid Panel, Standard. It measures Fasting Insulin before glucose turns abnormal and reads it with Hemoglobin A1c (HbA1c). In February 2026, the labeling of hormone therapy changed. A clinician who reads Dana's numbers can explain what that change means for her and decide case by case.
None of this requires a $20,000 retainer. It requires a decision about what is measured, how often and by whom. A concierge retainer buys access. Access has real value. By itself, it does not decide what is drawn or how often anyone reads the results with you. We do not know what any particular $20,000 practice includes. Some draw advanced panels. The questions worth asking are which markers, how often and who reads them with you.
Dana's first 90 days with GoodLife Health
What follows is what we would do for a member in Dana's situation. We will not invent her lab values, because a composite has none. We will say what is drawn, why it is drawn and what happens next.
Before day one: the check, the intake and the hold
Dana starts with the eligibility check. If she fits, she completes an intake and then checkout. At checkout, $598 is held on her card to cover the first two months. It is a hold, charged only once a clinician accepts her into care. If the clinician cannot accept her, the hold is released and she is never charged. Once she is accepted, the first two months are charged and are non-refundable.
Not everyone is accepted. A clinician reviews her intake, including what the hormone clinic currently prescribes, before she becomes a member.
Month 1: the panel before any plan
Her first cardiometabolic panel is one of four she will have in a year. It covers nine biomarkers, among them Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP, Fasting Insulin, Hemoglobin A1c (HbA1c), TSH With Reflex To Free T4 and Lipid Panel, Standard. Every result goes into her hands, so she can read it herself before anyone interprets it for her.
Each marker answers a question her last visit left open.
Fasting Insulin and Hemoglobin A1c (HbA1c) are read together. Her basic panel may have shown glucose. GoodLife Health measures fasting insulin before glucose turns abnormal. When weight moves and a basic panel explains nothing, the chain in the definitive guide begins at insulin, so that is where her clinician starts reading.
Apolipoprotein B (ApoB), Lipoprotein (A) and Hs-CRP are her cardiovascular baseline. ApoB and the lipid panel move after menopause. Dana is not there yet. The values drawn now become the ones every later panel is compared against, which is the plainest reason to draw them early.
The thyroid marker is in the same draw. Her clinician reads it beside insulin and lipids in one sitting. Dana does not have to request it at a separate visit or argue for it.
Her clinician then reads the results with her on a video visit. They go through each marker, what it suggests beside the others and what, if anything, should change. If her current hormone therapy needs review, it is reviewed against the same panel. Hormone therapy and thyroid medication are prescribed where indicated. The clinician decides.
One panel shows where the markers stand on one morning. The second, drawn about 90 days later, is the first point at which a direction can be read.
Month 2: between visits
Month two is quieter. Dana messages her care team between visits when a question comes up: a side effect, a night of poor sleep, a result she wants explained again. We do not promise a response time.
If her clinician judges a medication indicated, it is prescribed to the pharmacy Dana chooses at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. The membership fee is the same whatever medication is indicated and whatever the dose. There is no molecule upcharge and no dose upcharge.
If her panel and her clinician point toward a GLP-1, it would be branded and FDA-approved: Wegovy, Zepbound, Mounjaro or Ozempic. As published by the manufacturers in September 2026, Wegovy pens through NovoCare cost $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after. Zepbound vials through LillyDirect cost $299 to $449 a month depending on dose. No compounded GLP-1 is prescribed, ever. That is the clearest answer we can give to her pill-mill worry.
It is equally possible that nothing is prescribed in month two. Testing first means the honest answer can be to wait for the second panel before changing anything.
Month 3: the second panel
About 90 days after the first draw, Dana's second panel is drawn. For the first time, her markers have a direction instead of a single value. Her clinician compares the two panels with her. Together they decide whether the plan stays, changes or stops.
From month three, the membership is month to month at $299. Dana stays if the follow-through is useful to her. By the end of a year, she would hold four panels, each read against the last.
What the membership does not do
It does not replace insurance. Dana keeps her plan for catastrophic coverage: the hospital, the emergency and the specialist. The membership pairs with it.
It is precision direct primary care for cardiometabolic optimization. Within that scope, it replaces the primary-care relationship that gave her eight minutes and a basic panel. It is not a general practice for every complaint she might bring.
It is delivered by video visit and message. If what draws her to the concierge brochure is a doctor down the hall, we do not offer that.
It promises no amount of weight loss, no particular medication and no insurance coverage for any prescription. It prescribes branded, FDA-approved medication only. For a reader who has been offered research peptides or hormone pellets elsewhere, that is a deliberate choice.
Questions to ask any practice, including ours
| Question | GoodLife Health's answer |
|---|---|
| Which cardiovascular markers are drawn? | ApoB, Lp(a) and hs-CRP in every panel, beside the lipid panel |
| Is fasting insulin measured? | Yes, read with A1C |
| How often is blood drawn? | Four cardiometabolic panels a year |
| Who reads the results with you? | Your clinician, on a video visit, with every result in your hands |
| Does the practice earn on medication? | No. It takes nothing on medication. |
| What does a year cost? | $3,588 for the membership, with medication billed by the pharmacy |


Weighing it against the $20,000 practice
The year-one arithmetic is short. The membership is $3,588 a year. The practice in Dana's brochure is $20,000 a year. With GoodLife Health, medication is billed separately by the pharmacy at its own price. We cannot say what the concierge fee covers, so ask the practice directly. Our overview of what GoodLife Health is sets the two models side by side.
Price is not the strongest test either way. The stronger test is whether the care follows the blood. If a practice draws Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP and Fasting Insulin every quarter, reads them with you and earns nothing on what it prescribes, it is doing what we do at whatever price it charges. If it does all of that in person and you value the office, it may be worth its fee to you.
Dana also has a GP. The question is whether that relationship has ever produced a diagnosis for how she feels. Within cardiometabolic care, the membership is built to replace it. Her insurance still covers the hospital.
There are three things Dana can do this week whether or not she joins anyone. She can gather every result from her lab membership, her hormone clinic and her last physical into one file, so the next clinician sees the whole chain at once. She can ask her current doctor whether Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP and Fasting Insulin can be drawn. She can put the same questions to the concierge practice: which of those it draws, how often and who reads them with her. Each of those steps will tell her more than another brochure.
Who this is not for
If you want a GLP-1 prescription this week without a blood draw, this is not for you. The $99 apps are built for that purchase. We test first and would only slow you down. If you want a physician who visits your home or keeps an office near yours, a concierge practice may serve you better. If you are looking for compounded semaglutide, research peptides or hormone pellets, we prescribe none of them. If you need care well outside cardiometabolic health, keep your insurance and your specialists for it. If you live outside the United States, we cannot see you. Care is for residents of the 50 states.
If none of that describes you, here is the offer in full. The membership is $299 a month. At sign-up, $598 is held on your card for the first two months. It is charged only once a clinician accepts you. If you are not accepted, the hold is released and you are never charged. Once you are accepted, those two months are non-refundable. From month three, the membership is month to month. It buys four cardiometabolic lab panels a year with every result in your hands, a clinician who stays, messaging between visits and video visits. Medication, when indicated, is prescribed to your pharmacy at that pharmacy's price. GoodLife Health takes nothing on it. Medication billed by a pharmacy follows that pharmacy's own return and refund policy. What the membership returns is the diagnosis an eight-minute visit never produced, your markers followed over time and no repeat of that visit. It is different because it tests first and treats second. It sells neither the drug nor the dose. If you already pay for labs nobody reads with you and a hormone clinic that sees one link of the chain, your next panel can be the first one a clinician follows from quarter to quarter.
Related Reading
- Cardiometabolic Optimization: The Definitive Guide
- What Is GoodLife Health? Direct Primary Care, Explained (2026)
References
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings